Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes.

Endl J, Rosinger S, Schwarz B, Friedrich SO, Rothe G, Karges W, Schlosser M, Eiermann T, Schendel DJ, Boehm BO.

Diabetes. 2006 Jan;55(1):50-60.

2.
3.

OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccines.

Weinberg AD.

Trends Immunol. 2002 Feb;23(2):102-9. Review.

PMID:
11929124
4.

Autoreactive T cells in endocrine/organ-specific autoimmunity: why has progress been so slow?

Roep BO.

Springer Semin Immunopathol. 2002 Dec;24(3):261-71. Review.

PMID:
12503054
5.

T-cell assays to determine disease activity and clinical efficacy of immune therapy in type 1 diabetes.

van de Linde P, Roep BO.

Am J Ther. 2005 Nov-Dec;12(6):573-9. Review.

PMID:
16280651
6.

Insulin--a primary autoantigen in type 1 diabetes?

Wong FS.

Trends Mol Med. 2005 Oct;11(10):445-8. Review.

PMID:
16150642
7.

Regulation of CD4 T cell memory by OX40 (CD134).

Salek-Ardakani S, Croft M.

Vaccine. 2006 Feb 13;24(7):872-83. Epub 2005 Sep 7. Review.

PMID:
16176850
8.

The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement.

Weinberg AD, Evans DE, Thalhofer C, Shi T, Prell RA.

J Leukoc Biol. 2004 Jun;75(6):962-72. Epub 2004 Mar 2. Review.

9.

Regulatory T-cells in type 1 diabetes.

Juedes AE, von Herrath MG.

Diabetes Metab Res Rev. 2004 Nov-Dec;20(6):446-51. Review.

PMID:
15386802
10.

Autoimmune mechanisms in type 1 diabetes.

Knip M, Siljander H.

Autoimmun Rev. 2008 Jul;7(7):550-7. doi: 10.1016/j.autrev.2008.04.008. Epub 2008 Apr 30. Review.

PMID:
18625444
11.

The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure.

Roep BO.

Diabetologia. 2003 Mar;46(3):305-21. Epub 2003 Mar 22. Review.

PMID:
12687328
12.

Proinsulin-a pathogenic autoantigen in type 1 diabetes.

Narendran P, Mannering SI, Harrison LC.

Autoimmun Rev. 2003 Jun;2(4):204-10. Review.

PMID:
12848947
13.

Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus.

Monti P, Heninger AK, Bonifacio E.

Curr Diab Rep. 2009 Apr;9(2):113-8. Review.

PMID:
19323955
14.
15.

Deleting islet autoimmunity.

Liu E, Li M, Jasinski J, Kobayashi M, Gianani R, Nakayama M, Eisenbarth GS.

Cell Biochem Biophys. 2007;48(2-3):177-82. Review.

PMID:
17709887
16.

Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans.

Serreze DV, Chen YG.

Trends Immunol. 2005 Nov;26(11):603-7. Epub 2005 Sep 2. Review.

PMID:
16140038
17.

Activated T lymphocytes in Type 2 diabetes: implications from in vitro studies.

Stentz FB, Kitabchi AE.

Curr Drug Targets. 2003 Aug;4(6):493-503. Review.

PMID:
12866664
18.

GAD65 autoimmunity-clinical studies.

Uibo R, Lernmark A.

Adv Immunol. 2008;100:39-78. doi: 10.1016/S0065-2776(08)00803-1. Review.

PMID:
19111163
19.

Regulatory T cells and type 1 diabetes.

Homann D, von Herrath M.

Clin Immunol. 2004 Sep;112(3):202-9. Review.

PMID:
15308110
20.

Treg in type 1 diabetes.

Brusko T, Atkinson M.

Cell Biochem Biophys. 2007;48(2-3):165-75. Review.

PMID:
17709886
Items per page

Supplemental Content

Write to the Help Desk